Cargando…

Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Li, Tingting, Cai, Hongmin, Yao, Hebang, Zhou, Bingjie, Zhang, Ning, van Vlissingen, Martje Fentener, Kuiken, Thijs, Han, Wenyu, GeurtsvanKessel, Corine H., Gong, Yuhuan, Zhao, Yapei, Shen, Quan, Qin, Wenming, Tian, Xiao-Xu, Peng, Chao, Lai, Yanling, Wang, Yanxing, Hutter, Cedric A. J., Kuo, Shu-Ming, Bao, Juan, Liu, Caixuan, Wang, Yifan, Richard, Audrey S., Raoul, Hervé, Lan, Jiaming, Seeger, Markus A., Cong, Yao, Rockx, Barry, Wong, Gary, Bi, Yuhai, Lavillette, Dimitri, Li, Dianfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329378/ https://www.ncbi.nlm.nih.gov/pubmed/35896553 http://dx.doi.org/10.1038/s41467-022-32074-w

Ejemplares similares

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
por: Li, Tingting, et al.
Publicado: (2021)

A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
por: Yao, Hebang, et al.
Publicado: (2021)

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody
por: Li, Tingting, et al.
Publicado: (2021)

An improved fluorescent tag and its nanobodies for membrane protein expression, stability assay, and purification
por: Cai, Hongmin, et al.
Publicado: (2020)

Evaluating novel COVID-19 vaccines in the current chapter of the pandemic
por: GeurtsvanKessel, Corine H, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2
por: Li, Tingting, et al.
Publicado: (2022)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

The phosphatidylglycerol phosphate synthase PgsA utilizes a trifurcated amphipathic cavity for catalysis at the membrane-cytosol interface
por: Yang, Bowei, et al.
Publicado: (2021)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection
por: Neyt, Katrijn, et al.
Publicado: (2016)

Tertiary lymphoid organs in infection and autoimmunity
por: Neyt, Katrijn, et al.
Publicado: (2012)

Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7
por: Embregts, Carmen W. E., et al.
Publicado: (2021)

SARS-CoV-2 is transmitted via contact and via the air between ferrets
por: Richard, Mathilde, et al.
Publicado: (2020)

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
por: de Jong, Florus C., et al.
Publicado: (2023)

A Competitive Panning Method Reveals an Anti-SARS-CoV-2 Nanobody Specific for an RBD-ACE2 Binding Site
por: He, Siqi, et al.
Publicado: (2023)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Ongoing rabies outbreak in dogs of unprecedented scale and human cases in Nelson Mandela Bay Municipality, South Africa, up to 13 February 2022
por: Ravensberg, Matthijs F, et al.
Publicado: (2022)

Assessable learning outcomes for the EU Education and Training Framework core and Function A specific modules: Report of an ETPLAS WORKING Group
por: Dontas, Ismene A, et al.
Publicado: (2020)

Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
por: Embregts, Carmen W.E., et al.
Publicado: (2021)

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
por: Langerak, Thomas, et al.
Publicado: (2021)

Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands
por: Phan, My V. T., et al.
Publicado: (2019)

Rabies virus uniquely reprograms the transcriptome of human monocyte-derived macrophages
por: Embregts, Carmen W.E., et al.
Publicado: (2023)

Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2
por: Yu, Shi, et al.
Publicado: (2023)

Enhanced Enterovirus D68 Replication in Neuroblastoma Cells Is Associated with a Cell Culture-Adaptive Amino Acid Substitution in VP1
por: Sooksawasdi Na Ayudhya, Syriam, et al.
Publicado: (2020)

Erratum for Sooksawasdi Na Ayudhya et al., “Enhanced Enterovirus D68 Replication in Neuroblastoma Cells Is Associated with a Cell Culture-Adaptive Amino Acid Substitution in VP1”
por: Sooksawasdi Na Ayudhya, Syriam, et al.
Publicado: (2020)

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)

Characterizing Binding Kinetics and Thermodynamics of Computer-Designed Nanobodies Targeting SARS-CoV-2 RBD
por: Ferraz, Matheus, et al.
Publicado: (2021)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany
por: Hijnen, DirkJan, et al.
Publicado: (2020)

A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains
por: Yao, Hebang, et al.
Publicado: (2023)

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
por: Rockx, Barry, et al.
Publicado: (2020)

Both Conventional and Interferon Killer Dendritic Cells Have Antigen-Presenting Capacity during Influenza Virus Infection
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2009)

Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting
por: Voermans, Jolanda J.C., et al.
Publicado: (2019)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Structures of synthetic nanobody–SARS-CoV-2–RBD complexes reveal distinct sites of interaction and recognition of variants
por: Ahmad, Javeed, et al.
Publicado: (2021)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qkq311hk4eb99s68935triv0tl